Action of Lovastatin (Mevinolin) on an in vitro model of angiogenesis and its co-culture with malignant melanoma cell lines
2006

Effects of Lovastatin on Melanoma and Angiogenesis

Sample size: 3304 publication 10 minutes Evidence: moderate

Author Information

Author(s): Depasquale Ivan, Wheatley Denys N

Primary Institution: St John's Hospital, Livingston, UK

Hypothesis

Does Lovastatin affect the growth of melanoma cells and their angiogenic activity?

Conclusion

Lovastatin can reduce melanoma cell growth and angiogenic activity in co-cultures.

Supporting Evidence

  • Lovastatin inhibited the growth of all cell types in the study.
  • Statistically significant increases in tubule formation were observed in co-cultures.
  • Lovastatin's effects were reversed by geranylgeranyl pyrophosphate.

Takeaway

Lovastatin is a medicine that can help stop cancer cells from growing and making new blood vessels.

Methodology

The study used co-cultures of melanoma cell lines with human endothelial cells to assess the effects of Lovastatin on angiogenesis.

Potential Biases

Potential bias due to the authors' affiliations and funding sources.

Limitations

The in vitro model may not fully replicate the complex interactions in a living organism.

Participant Demographics

Participants were from a clinical trial with 3304 individuals, but specific demographics were not detailed.

Statistical Information

P-Value

0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-2867-6-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication